Log In
BCIQ
Print this Print this
 

B cell lymphoma 2 (BCL-2) (BCL2)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting B cell lymphoma 2 (BCL-2) (BCL2)

BCIQ
Print ChartPrint this
Registration, 1 Phase II, 4 Phase I/II, 1 Phase I, 4 Phase I, 1 Preclinical, 2
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase IIRegistration
Autoimmune

-

1

-

-

-

Cancer

2

4

1

4

1




 Products Targeting B cell lymphoma 2 (BCL-2) (BCL2)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

4

$525.0M

$225.0M

$300.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today